# US 2022/0030875 A1 · Composition comprising antimicrobial metal ions and a quaternary cationic surfactant

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0030875 A1
- Document ID: US20220030875A1
- Status: Published application
- Kind: A1
- Application number: 17/506,269
- Filed: 2021-10-20
- Published: 2022-02-03
- Earliest claimed: 2011-04-06
- Assignees: Convatec Technologies Inc.
- Applicants: Convatec Technologies Inc.
- Inventors: David PARSONS
- Web page: https://patentgrep.com/patent/US20220030875A1

## CPC

- A01N 59/16: Heavy metals; Compounds thereof
- A01N 33/12: Quaternary ammonium compounds
- A01N 37/44: containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
- A01N 59/20: Copper
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 9/06: Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)}
- A61K 31/14: Quaternary ammonium compounds, e.g. edrophonium, choline (betaines A61K31/205)
- A61K 31/198: Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00)
- A61K 33/24: Heavy metals; Compounds thereof
- A61K 33/245: Bismuth; Compounds thereof
- A61K 33/26: Iron; Compounds thereof
- A61K 33/30: Zinc; Compounds thereof
- A61K 33/32: Manganese; Compounds thereof
- A61K 33/34: Copper; Compounds thereof
- A61K 33/38: Silver; Compounds thereof
- A61P 17/02: for treating wounds, ulcers, burns, scars, keloids, or the like
- A61P 31/00: Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P 31/04: Antibacterial agents
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to an antimicrobial composition suitable for use on skin and wounds comprising a source of an antimicrobial metal ion and a quaternary cationic surfactant.

## Claims

### Claim 1

An antimicrobial composition for treating wound bacteria in a biofilm, the composition comprising ionic silver, EDTA at a level of from 0.01% to 10% by weight, and a quaternary cationic surfactant, wherein the quaternary cationic surfactant is present at a level of more than or equal to 0.025% by weight, wherein the composition has a pH from 4 to 8, wherein the ionic silver, the EDTA, and the quaternary cationic surfactant are present in the composition in amounts that provide synergistic antimicrobial activity against the wound bacteria, and wherein the composition is in the form of a thin soluble film, the thin soluble film being suitable for lamination to a wound dressing.

### Claim 2 (depends on 1)

A composition as claimed in claim 1, wherein the ionic silver is present at a level of from 0.00001% to 1.0% by weight of the composition.

### Claim 3 (depends on 1)

A composition as claimed claim 1, wherein the cationic surfactant is selected from a group of the salts where the cation is benzethonium, benzalkonium, dimethyldiakylonium, alkylpyridinium and alkyltrimethylammonium.

### Claim 4 (depends on 1)

A composition as claimed in claim 1, wherein the quaternary cationic surfactant is present at a level of from 0.05% to 4% by weight.

### Claim 5 (depends on 1)

A composition as claimed in claim 1, wherein the EDTA is present as a di-, tri- or tetra-basic salt of EDTA.

### Claim 6 (depends on 1)

A composition as claimed in claim 1, wherein the EDTA is present in the composition at a level of 0.1% to 4% by weight of the composition.

### Claim 7

A process for making an antimicrobial wound dressing comprising:
(i) obtaining an absorbent wound dressing, and
(ii) treating the wound dressing with an antimicrobial composition in the form of a thin soluble film, the thin soluble film being laminated to the wound dressing and for treating wound bacteria in a biofilm, wherein the composition comprises ionic silver, EDTA at a level of from 0.01% to 10% by weight, and a quaternary cationic surfactant, wherein the quaternary cationic surfactant is present at a level of more than or equal to 0.025% by weight, wherein the composition has a pH from 4 to 8, and wherein the ionic silver, the EDTA, and the quaternary cationic surfactant are present in the composition in amounts that provide synergistic antimicrobial activity against the wound bacteria.

### Claim 8 (depends on 1)

A composition as claimed in claim 1, wherein the quaternary cationic surfactant is selected from benzethonium chloride and benzalkonium chloride.

### Claim 9 (depends on 1)

A composition as claimed in claim 1 having a pH from 4.5 to 5.5.

### Claim 10 (depends on 1)

A composition as claimed in claim 1, wherein the quaternary cationic surfactant is present at a level of from 0.5% to 2% by weight.

### Claim 11 (depends on 1)

A composition as claimed in claim 1, wherein the EDTA is present in the composition at a level of 0.2% to 1% by weight.

### Claim 12 (depends on 1)

A composition as claimed in claim 1, having a pH of about 5.5 to protect peri-wound tissue by not altering its pH balance.

### Claim 13 (depends on 12)

A process as claimed in claim 12, wherein the composition has a pH from 4.5 to 5.5.

### Claim 14 (depends on 12)

A process as claimed in claim 12, wherein the composition has a pH of about 5.5 to protect peri-wound tissue by not altering its pH balance.

### Claim 15 (depends on 12)

A process as claimed in claim 12, wherein the EDTA is present in the composition at a level of 0.2% to 1% by weight.
